All Stories

  1. Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy
  2. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients
  3. Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients
  4. Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy
  5. Transplantation in highly HLA-sensitized patients: challenges and solutions
  6. Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin